Form 4: Alignment Healthcare Exec Sells Shares
Statement of Changes in Beneficial Ownership
Alignment Healthcare, Inc. reports a transaction where EVP Joseph S. Konowiecki sold 25,000 shares of common stock.
Summary
- Joseph S. Konowiecki, EVP of Corporate Affairs and Director at Alignment Healthcare, Inc., executed a transaction on July 1, 2026.
- The transaction involved the sale of 25,000 shares of common stock at a price of $24 per share.
- Following this transaction, Konowiecki beneficially owns 1,103,816 shares of common stock directly.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a negative sentiment due to an executive selling a notable amount of stock, which can be interpreted as a lack of confidence.
Negatives
- Executive Joseph S. Konowiecki sold a significant number of shares (25,000) at $24 each.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings typically report changes in beneficial ownership by insiders, such as directors and officers. Such transactions can sometimes signal insider confidence or lack thereof in the company's future prospects.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Plan Adoption | A transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 03/04/2026 | This indicates a pre-planned trading strategy by the executive, potentially mitigating concerns about opportunistic trading. |
Stakeholder Impact
- Shareholders may view the sale by an executive as a potential negative signal, possibly impacting short-term stock price sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/04/2026 | Date of adoption of Rule 10b5-1 plan. |
| 07/01/2026 | Transaction Date for sale of common stock and earliest transaction date. |
Recommendation
holdWhile the sale by an executive is a negative signal, the transaction was conducted under a Rule 10b5-1 plan, suggesting it was pre-arranged and not necessarily indicative of a fundamental change in the executive's long-term view of the company. The remaining substantial beneficial ownership also suggests continued commitment. Therefore, a 'hold' recommendation is appropriate pending further company performance indicators.
Keywords
Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Joseph S. Konowiecki, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.